Get the Stockscreener App
5.16
1.15%
-0.06
After Hours:
5.16
Trisalus Life Sciences Inc stock is traded at $5.16, with a volume of 75,801.
It is down -1.15% in the last 24 hours and up +23.44% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$5.22
Open:
$5.25
24h Volume:
75,801
Relative Volume:
0.76
Market Cap:
$257.32M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.9449
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
+1.18%
1M Performance:
+23.44%
6M Performance:
-10.42%
1Y Performance:
-1.71%
1-Day Range:
$5.0701
$5.265
1-Week Range:
$4.7806
$5.3326
52-Week Range:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.16 | 260.31M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
Visual analytics tools that track TriSalus Life Sciences Inc. performance2025 Bull vs Bear & Safe Swing Trade Setups - Newser
How to integrate TriSalus Life Sciences Inc. into portfolio analysis toolsQuarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
Combining price and volume data for TriSalus Life Sciences Inc. Equity Warrant2025 Top Gainers & Verified Entry Point Signals - Newser
Is TriSalus Life Sciences Inc. part of any ETF2025 Sector Review & Daily Growth Stock Tips - خودرو بانک
Is TriSalus Life Sciences Inc. a cyclical or defensive stock2025 Valuation Update & Precise Trade Entry Recommendations - خودرو بانک
Is TriSalus Life Sciences Inc. Equity Warrant undervalued by DCF analysisJuly 2025 Patterns & Growth Oriented Trade Recommendations - خودرو بانک
What the charts say about Credit Acceptance Corporation todayJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Uveal Melanoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Novartis, Foghorn Therapeutics Inc., TriSalus Life Sciences, Inc., AstraZeneca - The Globe and Mail
Is TriSalus Life Sciences Inc. Equity Warrant meeting your algorithmic filter criteriaTrade Signal Summary & Real-Time Volume Triggers - Newser
Predicting TriSalus Life Sciences Inc. trend using moving averagesPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
What the charts say about TriSalus Life Sciences Inc. todayWall Street Watch & Daily Profit Focused Screening - Newser
Trapped Investors in TriSalus Life Sciences Inc. Await Breakout Signal getLinesFromResByArray error: size == 0 - thegnnews.com
Candlestick signals on TriSalus Life Sciences Inc. Equity Warrant stock todayTreasury Yields & Weekly Chart Analysis and Trade Guides - Newser
Key resistance and support levels for TriSalus Life Sciences Inc.Weekly Market Outlook & Low Risk High Win Rate Stock Picks - Newser
Comparing TriSalus Life Sciences Inc. in custom built stock radarsStock Surge & Free High Accuracy Swing Entry Alerts - Newser
Detecting price anomalies in TriSalus Life Sciences Inc. with AI2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
What does recent volatility data suggest for TriSalus Life Sciences Inc.Market Trend Review & Real-Time Volume Analysis Alerts - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Weekly Trades: Can TriSalus Life Sciences Inc. Equity Warrant navigate macro headwinds2025 Key Lessons & Weekly Momentum Picks - خودرو بانک
Reversal indicators forming on TriSalus Life Sciences Inc. Equity Warrant stock2025 Technical Overview & Stepwise Trade Signal Implementation - Newser
Can swing trading help recover from TriSalus Life Sciences Inc. losses2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
How to build a custom watchlist for TriSalus Life Sciences Inc.Portfolio Growth Summary & Community Supported Trade Ideas - Newser
Is TriSalus Life Sciences Inc. Equity Warrant currently under institutional pressure2025 Key Highlights & Smart Swing Trading Techniques - خودرو بانک
Can TriSalus Life Sciences Inc. be recession proofJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Analyzing TriSalus Life Sciences Inc. with risk reward ratio charts2025 Price Targets & High Accuracy Trade Alerts - Newser
Does TriSalus Life Sciences Inc. have pricing powerInsider Selling & Low Drawdown Investment Strategies - خودرو بانک
Will TriSalus Life Sciences Inc. bounce back from current supportWeekly Gains Summary & Community Verified Swing Trade Signals - Newser
Key resistance and support levels for TriSalus Life Sciences Inc. Equity Warrant2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
What’s next for HCA Healthcare Inc. stock priceStock Surge & Scalable Portfolio Growth Ideas - Newser
Will a bounce in TriSalus Life Sciences Inc. Equity Warrant offer an exit2025 Year in Review & Stepwise Trade Signal Guides - Newser
Comparing TriSalus Life Sciences Inc. Equity Warrant in custom built stock radarsJuly 2025 Breakouts & High Conviction Trade Alerts - Newser
Published on: 2025-08-31 15:12:23 - Newser
Will TriSalus Life Sciences Inc. stock go up soon2025 Valuation Update & Fast Moving Stock Trade Plans - Newser
Ranking High Roller Technologies Inc. among high performing stocks via toolsWeekly Risk Report & AI Forecasted Entry and Exit Points - Newser
Forecasting TriSalus Life Sciences Inc. Equity Warrant price range with options dataTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
What technical models suggest about TriSalus Life Sciences Inc.’s comebackGlobal Markets & Daily Price Action Insights - Newser
Intraday pattern recognizer results for TriSalus Life Sciences Inc.Weekly Profit Recap & Pattern Based Trade Signal System - Newser
Regression analysis insights on TriSalus Life Sciences Inc. performance2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Will Integra LifeSciences Holdings Corporation outperform the market2025 Performance Recap & Detailed Earnings Play Strategies - Newser
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):